Skip to Content

Leuprolide Acetate 14-Day Kit

Last Updated: March 10, 2018
Status: Current

Leuprolide Acetate 14-Day Kit

Products Affected - Description
  • Leuprolide Acetate injection, Sandoz
    1 mg/0.2 mL, 2.8 mL multiple dose vial, 14 day kit (NDC 00781-4003-32)

 
Leuprolide Acetate injection, Sun Pharma
1 mg/0.2 mL, 2.8 mL multiple dose vial, 14 day kit (NDC 47335-0936-40)
 
Leuprolide 1 mg/0.2 mL Injection, Teva
2.8 mL multiple-dose vial with 14-day kit (NDC 00703-4014-18)
Reason for the Shortage
    • Sun Pharma did not provide a reason for the shortage.
    • Sandoz states the reason for the shortage was increased demand.
    • Teva states the shortage is due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Sandoz has leuprolide acetate injection on intermittent back order with regular releases.
    • Teva has leuprolide acetate injection on long-term back order and the company cannot estimate a release date.
    • Sun Pharma has leuprolide acetate injection on back order and the company cannot estimate a release date.

Updated

March 10, January 29, 2018; September 22, July 18, May 5, February 28, 2017; November 30, September 9, June 14, April 11, January 27, 2016; December 9, November 4, September 29 and 9, June 22, April 29, March 23, February 25 and 4, January 15, 2015; December 17, November 19, September 11, June 23, April 15, February 14, January 15, 2014; September 26, July 16, May 15, March 22, February 7, January 9, 2013; November 12, August 13, June 21, April 20, March 2, February 3, 2012; December 28 and 1, October 27, August 19, July 22, June 24 and 3, May 5, March 24, February 25, 2011, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide